UC San Diego researchers have released the first genome-scale CRISPRi atlas of human induced pluripotent stem cells, mapping the effects of 11,692 genes across 2.5 million single cells. Published in Nature Biotechnology in July 2026, the open resource functions as a searchable “hypothesis engine” for gene function, differentiation control, and virtual cell modeling, extending the legacy of the Human Genome Project into dynamic cellular regulation.
Key Takeaways by Planet Today:
A Searchable Atlas Changes the Pace of Discovery: By turning gene-by-gene experiments into an open lookup tool, the map compresses years of groundwork into hours of hypothesis generation, potentially shortening paths from lab insight to patient-specific therapies.
Hidden Metabolic and Self-Renewal Genes Surface: Previously obscure regulators, including DBR1 as a primary driver of A-to-I RNA editing, now stand out as actionable targets for controlling stem-cell identity and differentiation.
Virtual Cell Models Move Closer to Reality: The data set supplies training material for computational and AI systems that predict genotype-to-phenotype outcomes, reducing reliance on animal models and accelerating drug screening for degenerative conditions.
Open Access Lowers Barriers Across Labs: Researchers worldwide can query effects without repeating the full CRISPRi screen, democratizing high-throughput functional genomics while highlighting remaining gaps in dynamic gene regulation. {alertInfo}
Scientists at the University of California San Diego have published the first genome-scale functional map of human induced pluripotent stem cells, creating what they describe as a “genetic dictionary” and “hypothesis engine.” The open-access atlas, released in Nature Biotechnology on 1 July 2026, systematically records how switching off each of 11,692 expressed genes alters the transcriptome across more than 2.5 million individual cells.
The work builds directly on the static sequence delivered by the Human Genome Project more than two decades earlier. Where that earlier effort catalogued the letters of the genetic code, the new map tracks what those letters do when temporarily silenced inside living stem cells that can become almost any tissue in the body.
How the Atlas Was Built
The team, led by bioengineer Prashant Mali, used CRISPR interference (CRISPRi) to dial down gene activity one by one without permanently cutting the DNA. Effects were read out by single-cell RNA sequencing, capturing the full transcriptome of each perturbed cell. Related genes were then grouped according to shared molecular signatures, revealing coherent functional modules that had remained hidden in smaller-scale studies.
“The result is a kind of reference atlas; it’s a way to look up what perturbing almost any gene does to a stem cell’s behavior, measured here as the impact on its whole transcriptome,” Mali said in the university’s announcement.
Co-first author Yesh Doctor, a bioengineering PhD student in Mali’s lab, added: “The map we generated works as a hypothesis engine—it’s a starting point for what a given gene does and which genes might be worth pursuing as targets to drive differentiation into cell states of interest. Scientists can use it to look up the functions of genes and build hypotheses on them instead of having to run the experiments themselves.”
The data set is publicly viewable at an interactive portal and the underlying processed counts are deposited on Figshare. Raw sequencing files are available through NCBI under BioProject PRJNA1173491, subject to standard access conditions from the cell-line provider.
Key Discoveries That Stood Out
Beyond confirming expected pluripotency networks, the screen isolated previously under-appreciated metabolic regulators and self-renewal factors. One clear example is the gene DBR1, identified as the dominant regulator of adenosine-to-inosine RNA editing in these cells—an editing process that can alter protein-coding sequences and fine-tune cellular responses.
Other newly highlighted genes include ZBTB41, linked to metabolic control, and RNF7, tied to pluripotency maintenance. Experimental follow-up confirmed several of these roles, giving the computational clusters biological weight.
The scale—11,692 genes interrogated across 2.5 million cells—makes this the most comprehensive functional snapshot of human iPSCs to date. Earlier CRISPR screens typically covered far fewer genes or used bulk rather than single-cell readouts, limiting resolution of subtle or cell-state-specific effects.
If a laboratory can now query the effect of nearly any expressed gene without repeating the full experimental pipeline, how might that change the balance between pure computational prediction and traditional wet-lab validation over the next decade?
Implications for Regenerative Medicine and Beyond
Human induced pluripotent stem cells can be generated from a patient’s own skin or blood cells and then directed into neurons, cardiomyocytes, retinal tissue or other specialized types. Knowing which genes push cells toward or away from particular fates accelerates the design of differentiation protocols and the identification of disease-relevant pathways.
Mali noted that genome-scale screens of this kind also supply high-quality training data for future AI models that aim to predict genotype–phenotype relationships—one of the central unsolved problems in genetics. Virtual cell models built on the atlas could, in principle, let researchers test thousands of genetic interventions computationally before selecting a handful for costly laboratory confirmation.
In practical terms the resource may speed screening of drug candidates on patient-derived cells, reduce dependence on animal models for early-stage testing, and help engineers produce replacement tissues with greater precision. Parallel advances in natural-product research, such as recent laboratory work on dandelion-root extracts showing selective toxicity toward certain cancer cells (detailed here), illustrate how complementary approaches—synthetic gene maps and carefully studied plant compounds—can both inform future therapeutic strategies.
Related cellular-health findings, including a garlic-derived compound that appears to support muscle maintenance through inter-organ signaling (reported separately), further underscore the value of mapping molecular regulators across scales.
Context and Caveats
The atlas covers expressed genes in one widely used iPSC line under defined culture conditions. Effects can vary with genetic background, culture media, or differentiation stage, so the map functions as a powerful starting point rather than a universal rulebook. Researchers will still need to validate high-priority hits in their own systems.
Funding came from the National Institutes of Health (including the Bridge2AI program and NHGRI), the California Institute for Regenerative Medicine, the Department of Defense, and institutional support. The paper appears as Nourreddine, S., Doctor, Y., et al., “A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells,” Nature Biotechnology (2026), DOI: 10.1038/s41587-026-03199-w.
While this account draws from the peer-reviewed publication, the official UC San Diego release, and contemporaneous reporting in outlets such as News-Medical and Phys.org, readers seeking complete methodological detail should consult the primary paper and supplementary data. Independent verification remains essential.
The open atlas is already available for the community to explore. Its real test will be how many new experimental hypotheses it generates and how quickly those hypotheses move from screen to validated biology.